S-1
S-1
- Company
- Nautilus Biotechnology, Inc.
- Filed
- July 21, 2020
- Accession Number
- 0001140361-20-016469
An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →